-A A +A
December 18, 2013

In budget-constrained times, adopting new drugs or medical technology is a high-stakes challenge that requires a comprehensive, balanced approach, according to a report released today by the C.D. Howe Institute.  In “Capturing Value from Health Technologies in Lean Times,” authors Ake Blomqvist, Colin Busby and Don Husereau argue healthcare policymakers should make greater use of Health Technology Assessment (HTA), a policy tool that can help them balance demand and supply pressures for new technologies within a health-system budget.

 

Åke Blomqvist
Åke Blomqvist

Health Policy Scholar, C.D. Howe Institute

Åke Blomqvist received his undergraduate education in his native Sweden, and a PhD from Princeton University in 1971. He is Professor Emeritus at the University of Western Ontario where he taught between 1968 and 2002.

Colin Busby
Colin Busby

Colin Busby was awarded the 2007 C.D. Howe Research Fellowship and joined the Institute as an analyst thereafter. While writing broadly on economic issues, his emphasis is on fiscal and social policy. Appointed Associate Director of Research in 2016, Colin focuses his attention on the Institute’s healthcare policy and human capital research.